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Jennifer W Leiding1, Douglas Beakes2, Stephen C Dreskin3, Anete Grumach4, Michihiro Hide5, Avner Reshef6,
Massimo Triggiani7 and Michael A Kaliner8*This month for listing within the World Allergy
Organization Journal is a paper that represented an in-
novative experiment first proposed and carried out by Dr.
Michael Kaliner. In this paper an interesting case is dis-
cussed by a local training program, or programs, in the
Washington DC area. The case centers on a particularly
difficult subject in allergy management on the subject of
angioedema. The original discussion is included, and then
comments from expert individuals from five regions of the
world were solicited and correlated so that each of the
points of view concerning the different regions were regis-
tered. This effort took some time to get off the ground,
and I believe the initial offering of WAO International
Case-based Discussions will generate enough enthusiasm
and lead to routine discussions to be published in the
Journal. The approach invites consideration and compari-
son of viewpoints from various areas of the world on a
specific difficult clinical case.
Again, it was a challenge to pull together. Michael Kaliner
and Sofia Dorsano are to be commended for their efforts.
As the series expands, it will be quite interesting to follow
the different points of view and the regions of the world
concerning the common allergy problems we all face.
Lanny J. Rosenwasser, MD
President, World Allergy Organization
Case report
A 45 year-old Caucasian male presents with approxi-
mately 12 episodes of tongue swelling over the last year.
Each episode occurs upon awakening in the morning, is
preceded by tongue tingling, and is not associated with
swelling in other locations of his body. He has no associ-
ated airway obstruction but does have difficulty talking
and closing his mouth due to the degree of swelling. He* Correspondence: makaliner@aol.com
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stated.has no history of urticaria and does not develop hives in
conjunction with tongue swelling. He denies any other
signs or symptoms of anaphylaxis.
The patient has been evaluated in the emergency room
for many of these episodes and treated with diphenhydra-
mine, prednisone, and ranitidine with improvement in
symptoms within an hour of receiving medication. He has
also self-treated many episodes with diphenhydramine at
home with quick resolution of symptoms. Other times, he
has had symptoms of only tongue tingling and is able to
abort an episode of swelling with quick treatment with di-
phenhydramine. He has no history of allergic rhinitis, al-
lergic skin disorders, or food allergy. He has not noticed
any specific seasonality, food ingestion, rhinitis, or ocular
symptoms associated with episodes.
On review of systems, patient complained of frequent
indigestion and heartburn for the last year but denied hali-
tosis, acidic taste in his mouth, or cough. He has no his-
tory of mouth sores or ulcers, dental caries, or gingivitis.
Laboratory evaluation included normal complete blood
count, chemistries, and liver function tests. Thyrotropin
was 2.7 mIU/ml (0.27-4.2), C4 25.3 mg/dL (10-40), C1 es-
terase inhibitor quantity 12 mg/dL (11-26), and C1 ester-
ase inhibitor function >100% (>68%).
After initial evaluation, daily antihistamine therapy was
initiated and patient had complete resolution of episodes
of angioedema with the exception of one episode after
missing two days of therapy. Helicobacter pylori IgG was
also evaluated due to the patient’s complaints of heart-
burn. With a positive history and an elevated H. pylori
IgG at 1.36 u/mL (1-1.09), patient was treated with triple
drug therapy including: amoxicillin, clarithromycin, and
omeprazole. After therapy for H. pylori eradication, patient
discontinued treatment of fexofenadine and within 1 day
had an episode of angioedema of the tongue. He restarted
daily fexofenadine and has remained free of episodes of
angioedema.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Stephen Dreskin (North America)
Idiopathic angioedema is a significant clinical entity that is
poorly studied. When a patient presents with episodic
swelling in the absence of urticaria, the Allergist/Immun-
ologist first must rule out the bradykinin-mediated angio-
edemas such as those caused by ACE inhibitors and those
due to deficiency of C1 esterase inhibitor [1-3]. The obser-
vation, such as in this patient, that symptoms improve on
blockade of H1 receptors, suggests that the process is me-
diated, at least in part, by histamine, a product of mast
cells. To produce angioedema in the absence of urticaria,
it is likely that the mast cells being activated are in the
sub-dermis. So, it is not unreasonable to think of idio-
pathic angioedema in the same way we think of idiopathic
urticaria. The main difference is that in idiopathic angio-
edema the activated mast cells reside in sub-dermis
whereas in idiopathic urticaria they reside in the dermis.
In addition to highlighting the clinical challenge of
idiopathic urticaria this case report also raises the issue
as to whether infection with H. pylori plays a role in
chronic urticaria and/or in idiopathic angioedema. This
patient was noted to have an elevated H. pylori IgG but
did not have resolution of his angioedema following
treatment designed to eradicate the infection. This raises
two related questions: The first is whether there is any
reasonable pathophysiologic mechanism to explain an
association between infection with H. pylori and idiopathic
angioedema, and the second is whether there are any clin-
ical data to support this treatment. In regard to the first
question, the literature on idiopathic angioedema and
chronic idiopathic urticaria has frequently included a
potential etiologic role for any chronic infection, possibly
acting via immune complex formation or by innate
immune pathways.
Regarding clinical data to support such treatment, there
are rare case reports to suggest that eradication of
H. pylori can help idiopathic angioedema [4]. However,
given the similarities between chronic urticaria and idio-
pathic angioedema, is it reasonable to review the evidence
that eradication of H. pylori can help patients with chronic
urticaria? Federman and colleagues performed a meta-
analysis of 10 studies (274 subjects) addressing this ques-
tion with at least modest rigor including evidence that
eradication was successful [5]. Overall, successful treat-
ment of H. pylori infection was both quantitatively and
statistically associated with remission of urticaria with an
odds ratio of (OR) = 2.9 (1.4-6.8; p = 0.005) compared to
subjects who were H. pylori positive without eradication.
The British Association of Dermatologists Therapy Guide-
lines and Audit Subcommittee felt that these data reached
a “strength of recommendation level” of “B”, stating there
is “fair evidence to support the use of the procedure” [6].
In spite of these data, the utility of examining patients forevidence of H. pylori infection is not generally accepted
and has been questioned due to the frequency of this
infection in asymptomatic individuals [7].
In conclusion, it is reasonable to undertake eradication
of H. pylori infection in an attempt to modify the natural
history of idiopathic angioedema, although the evidence
that this would be effective is scant. That said, this case re-
port is missing an important step which is to demonstrate
that the eradication of H. pylori was successful. This can
be accomplished by assaying persistence of H. pylori anti-
gen in stool [8].
Anete Grumach (Central and South America)
It is presented a male patient whose symptoms, mainly
tongue swelling, began late, at 45 years old. Genetic dis-
orders usually manifest early in life, for example, heredi-
tary angioedema (HAE). The experience with Brazilian
patients has shown that 82% of the HAE patients pre-
sented their first symptoms before 10 years old [9].
The tongue was the only location affected, and this is
more common for angioedema caused by angiotensin
converting enzyme (ACE) in patients treating hyperten-
sion [10]. Brazilian HAE patients had facial angioedema in
108 out of 170 but not restricted to the tongue. Allergic
angioedema, usually, affects other parts of the body. The
patient did not report urticaria or previous history of al-
lergy. On the other hand, several episodes were treated
with anti-histamines and steroids, with improvement.
No common triggering factors could be identified by the
patient. In our experience with HAE (Brazil; n = 210),
trauma was reported by 41.9% (n = 88), followed by stress
reported in 26.7% (n = 56). In addition, menses and food
were also mentioned in 9.5% and 6.7% of the patients.
Considering that ¼ referred stress and approximately 10%
did not identify the cause of the attack, it was expected
that the patient could not explain the cause of his pain.
Frequent complaints of gastric symptoms were referred,
coincident with the initial clinical manifestations in the re-
ported patient. Abdominal pain is the second most fre-
quent symptom reported by HAE patients and epigastric
complaints are also common; 43% of HAE patients in our
experience. So, the pain referred by the patient could be
misdiagnosed as associated with the genetic defect. In
contrast, food allergy could be another hypothesis [11].
The gastric manifestation with heartburn directed the
physician to the search of gastritis, and the test resulted
positive for H. pylori. IgG antibodies confirmed the diag-
nosis. Specific therapy for H. pylori improved the occur-
rence of angioedema, suggesting that this was the
triggering factor. Visy et al. (2007) in a collaborative study
of seven centers reported the improvement of the fre-
quency of HAE attacks after identifying and treating
H. pylori [12]. In Brazil, the screening for H. pylori in pa-
tients with HAE is not a routine. Moreira et al. (2004)
Leiding et al. World Allergy Organization Journal 2014, 7:2 Page 3 of 6
http://www.waojournal.org/content/7/1/2found that the occurrence of H. pylori in children repre-
sents an odds ratio of 4 for developing urticaria [13].
H. pylori had also been reported as a worsening factor
for Hereditary Angioedema [4,12].
Laboratorial tests excluded hereditary angioedema.
Farkas et al. (1999) reported a patient with H pylori in-
fection and acquired C1 esterase inhibitor deficiency due
to a possible increased consume of complement [14].
This is not the case, because the patient had normal
values of complement proteins except for the fact that
C1 inhibitor level was close to the lower limit.
Michihiro Hide (Asia Pacific)
I made a diagnosis of idiopathic or spontaneous angio-
edema for this patient.
In spite of detailed classifications by the guidelines for
urticaria, prepared by EAACI and approved by WAO and
several other academic organizations [15], angioedema has
still not been well classified, except for subtypes of heredi-
tary angioedema. Recently the Japanese Association of
Dermatologists (JDA) revised the guidelines for urticaria
and angioedema and classified angioedema into three
types: idiopathic angioedema, angioedema due to exogen-
ous factors, and hereditary angioedema [16]. Idiopathic
angioedema is a counterpart in angioedema for idiopathic
urticaria which was designated in the JDA guidelines.
Therefore, this subtype may well be described as spontan-
eous angioedema.
The only one possibility that the author(s) should
clearly rule out is the use of angiotensin-converting en-
zyme inhibitor by this patient [17,18]. The continuous,
rather than occasional, use of a drug in this category
may reduce the threshold for the appearance of angio-
edema, which resembles idiopathic urticaria. Namely,
patients may intermittently develop angioedema without
wheals (superficial and demarcated skin edema) without
apparent direct stimuli. However, as far as I know, this
type of angioedema is resistant to medication, including
anti-histamines. In case the patient described in this re-
port had been taking angiotensin-converting enzyme, he
should have first quit this medication.
The association or non-association of wheals with an-
gioedema should be a matter of discussion. The statistical
archive reported by Champion about patients with urti-
caria and angioedema [19], and literature written by many
other European and American authors suggest that about
half of patients who suffer from chronic idiopathic urti-
caria, namely wheals, may also develop angioedema [20].
However, this is not applicable to Japanese and probably
other Asian patients. I, and many of my colleagues in
Japan, have an impression that angioedema and the other
subtypes of urticaria are not complicated so frequently. A
retrospective study of 260 patients with urticaria and an-
gioedema who visited the outpatient clinic of HiroshimaUniversity Hospital from 2003 to 2005 revealed the popu-
lation of patients who solely or dominantly suffered from
angioedema was 4.2%. Among patients who suffered from
chronic spontaneous urticaria (56.2%), only 29 out of 146
patients were complicated with angioedema [21].
A surprising feature of the patient reported here is a good
responsiveness to anti-histamines. Oral anti-histamines are
the first line medication for idiopathic angioedema but may
not completely prevent and suppress symptoms as ob-
served in this report. In a viewpoint of clinical practice, the
way of taking medication is important. Unlike spontan-
eously occurring acute and chronic urticarias, symptoms of
angioedema do not appear on a daily basis. Therefore, it
might be practical to take medication only when a symp-
tom begins to appear or be felt by the patient. In the case
of this patient, it seems to be better to take daily anti-
histamine therapy, since the symptoms were severe, and he
developed symptoms as early as two days after the cessation
of the treatment. It would be a good practice, however, to
reduce the amount of anti-histamine and/or prolong the
interval of intake to the level where the patient does not
develop symptoms. I expect the disease activity of this pa-
tient to gradually decrease over the course of treatment
and eventually diminish so that he can be free of daily
medication.
Avner Reshef (Middle East/Africa)
This case presentation involves a 45 year-old male with
recurrent episodes of isolated tongue swellings, occur-
ring over a period of one year. Most episodes exacerbate
upon awakening in the morning, and the patient cannot
point at any noticeable triggers, such as foods, medica-
tions, stings or infection. These episodes are not accom-
panied by pruritic rash or signs of systemic anaphylaxis,
and seem to respond well to antihistamines and cortico-
steroids. Laboratory evaluation is negative for C1 ester-
ase Inhibitor (C1INH) deficiency, as the C4 and both
antigenic and functional levels of the enzyme are nor-
mal. No family members with hereditary angioedema
were mentioned. A trial of H. Pylori eradication protocol
failed to relieve the recurring tongue swelling episodes.
Experienced allergists and ENT specialists and Emer-
gency Department personnel are familiar with this condi-
tion, as they are often called to treat and work-up these
patients. Angioedema has a wide variety of differential
diagnoses that can be mechanistically divided into two
major entities: Histamine-mediated swellings are typically
allergic or anaphylactic, very often accompanied by in-
tensely pruritic rash (urticaria), while Kinin-mediated
edema occurs silently and gradually and involve single or
multiple sites. In terms of triggers, the earlier condition is
associated with exposure to allergens (i.e. foods, stings) or
drugs (Aspirin, NSAIDs, ACE Inhibitors), while the other
includes hereditary and acquired forms of C1INH
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trauma, infections, and hormones. Rare conditions of
tongue swelling and macroglossia include: granuloma-
tous cheilitis (Melkersson-Rosenthal Syndrome), aller-
gic contact dermatitis, lymphedema, lymphangioma,
and capillary-leak syndrome.
Zingale et al. recently reported a series of 929 cases of
Angioedema without urticaria observed in a tertiary-care
clinic in Italy over 11 years period, of which 776 could be
evaluated [22]. The face and oral cavity were the most af-
fected areas. Hereditary or acquired angioedema due to
C1INH deficiency was diagnosed in 25%. In patients with
identified etiology, medications were a possible cause in
45% (mostly ACE Inhibitors), foods in 36%, and only 7%
had a concomitant disease (i.e. infection or autoimmune).
H. pylori infection was evident in two patients, of which
only one responded to eradicative therapy. In 38% of cases
a cause could not be elucidated, of which 1/3 could be cat-
egorized as idiopathic-histainergic edema. Patients with
negative laboratory work-up received a long-term antihis-
tamine treatment, for which 86% responded well. A few
unresponsive patients improved on tranexamic acid. The
authors propose a useful algorithm for the work-up of an-
gioedema without urticaria patients.
I would urge clinicians to extensively investigate patients
with recurrent facial or oral cavity angioedema, which can
potentially evolve into a disturbing and sometimes life-
threatening condition. A careful medication history will
sometimes reveal a forgotten over-the-counter NSAID
taken before bed for a simple headache, or an ACE Inhibi-
tor prescribed for hypertension and skipped by the patient
at presentation. A careful work-up by oral specialist will
be helpful if local involvement is suspected (MRS, lymph-
edema, lymphoma).
We have seen in our angioedema clinic a few cases of
base-of-tongue and uvular edema in patients with obstruct-
ive sleep apnea (OSA) and relentless snoring. We can only
speculate on the role of vibratory forces applied by snoring
as a cause of local mediator release and vascular hyper-
permeability. Laser uvulectomy was helpful in isolated cases.
Therapeutic options for idiopathic angioedema without
urticaria are still antihistamines (preferentially 2nd gener-
ation) and short-term course of corticosteroids. We pre-
scribe tranexamic acid (Hexacapron) 1-1.5 grams b.i.d as a
long term prophylaxis regimen for non-responsive pa-
tients, particularly where non-histaminergic edema is sus-
pected. The efficacy of the new kinine-system antagonists
(icatibant, Firazyre® or ecallantide- Kalbitor®) is presently
unclear.
Massimo Triggiani (Europe)
The case presented can be considered as an idiopathic
histaminergic angioedema. This is a diagnosis made by
exclusion of other forms of recurrent angioedema suchas those clearly related to an allergic reaction or those
due to C1 inhibitor deficiencies (hereditary or acquired).
Systemic diseases, such as autoimmune, lymphoprolifera-
tive or infectious diseases, that can be eventually associated
with recurrent angioedema, should have been ruled out by
clinical and laboratory findings. Rare forms of angioedema,
such as that associated with eosinophilia (Gleich’s syn-
drome) are not under consideration because of the normal
blood count and response to antihistamines. Although no
specific information is given whether the patient was on
treatment with drugs that can induce angioedema, includ-
ing ACE inhibitors and ASA, we should expect that the hy-
pothesis of drug-induced angioedema was excluded.
What is really striking in this case is the fact that angio-
edema apparently occurred always at the same location
(the tongue), with no extension to adjacent areas, and at
the same time of the day (in the morning). These features
may suggest a local factor triggering angioedema and/or a
possible exposure to an eliciting factor during the night or
early morning. Oropharyngeal infections and previous
dental problems, including dental fillings that could cause
hypersensitivity, are apparently excluded by the history. In
this regard, it would be useful to get information on
whether there is occasional use of mouth washings in the
morning or whether there is a candidiasis of the tongue.
Another possibility that may be taken into diagnostic con-
sideration is a form of physical angioedema. Angioedema
can be elicited by physical stimuli such as vibration, pres-
sure, and heat. Although urticaria is most frequently re-
lated to physical stimuli, isolated angioedema has also
been reported and these forms can even be responsive to
antihistamines. I would also do tests for physical urticaria/
angioedema, and I would check whether there is any asso-




This article initiates the series of International Case-based
Discussions that should appear periodically in this journal
hereafter. The idea is to present cases that are discussed
from different perspectives, taking advantage of the global
presence of the World Allergy Organization. Today’s case
is that of recurrent tongue angioedema that was controlled
by regular use of oral antihistamines.
While no one provided specific insight into what
might be the root cause of this patient’s disorder, it was
fascinating to see how the discussions ranged from idio-
pathic urticaria and angioedema to H. pylori to HAE.
Unfortunately, no one had a specific proposal for this
patient’s problem but all suggested that it had to be his-
tamine initiated (by nature of the effectiveness of oral
antihistamines) and thereby suggesting that an allergic
mechanism was at play. There is no evidence of either
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recurrent syndrome suggests idiopathic mast cell activation
of the tongue, perhaps through a non-immunologic mech-
anism such as a neurogenic stimulus. Many of our angio-
edema patients have special sites where their swelling
occurs more frequently than other sites, but it is uncom-
mon to find a sole site, such as the tongue. One reviewer
suggested a possible link to snoring, which is a fascinating
idea in this patient.
The idea that H. pylori infection might be involved was
discussed by most reviewers and the consensus is that the
overall evidence weighs against this causative relationship.
A possible additional cause might be reflux of gastric fluid
overnight into the mouth with specific tongue swelling.
Each episode occurred overnight with swelling upon awak-
ening. Every clinician is aware that many allergic subjects
awaken and shortly thereafter get sneezing and other nasal
manifestations of allergic rhinitis, suggesting that the
process of awakening allows these reactions to manifest. It
has always seemed unexpected that some subjects can re-
flux into their throat and nose while in bed in a recumbent
position and cause pharyngeal, nasal, sinus, and possible
mouth symptoms without being aware of the reflux. How-
ever, it would be difficult to explain how this reflux might
cause recurrent tongue swelling but no other mouth
symptoms.
As with all good case discussions, there are questions
remaining without adequate answers; thus the need for ex-
pert commentary. This article starts the process of inter-
national discussions and we anticipate that there will be
more coming in the future issues of the World Allergy
Organization Journal. We all hope that the readers enjoy
this new feature.Consent
Written informed consent was obtained from the patient
for the publication of this report.Competing interest
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